Toggle navigation
Home
Search
Services
Blog
Contact
About
Molecular Imprint Mediated Pharmacophore Translation
Wilson, Mark E.
University of California Irvine, Irvine, CA, United States
Search 280 grants from Mark Wilson
Search grants from University of California Irvine
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Sequencing not required: Imputing rare variants into a cohort of 100,000 on aging
Molecular Mechanisms of Treponema Denticola Adherence
Cytokine Regulation of HLA Class I in Endothelial Cells
Calcium Signaling in Vascular Endothelial Cells
Biomedical Research Support
Recently added grants:
NIDDK Short-Term Education Program for Underrepresented Persons at UCLA (UCLA STEP-UP)
Synaptic Processing in the Vestibular System
MyD88-dependent B cell dysfunction and autoimmunity during chronic liver disease
Epigenetic Mechanisms in Type 1 Diabetes
Dynamics and Health Consequences of Obesity between Infancy and Young Adulthood in the United States
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32GM019022-01
Application #
2417105
Study Section
Special Emphasis Panel (ZRG3-MCHA (01))
Project Start
1998-02-25
Project End
Budget Start
1997-09-01
Budget End
1998-08-31
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Institution
Name
University of California Irvine
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
161202122
City
Irvine
State
CA
Country
United States
Zip Code
92697
Related projects
NIH 1998
F32 GM
Molecular Imprint Mediated Pharmacophore Translation
Wilson, Mark E. / University of California Irvine
NIH 1997
F32 GM
Molecular Imprint Mediated Pharmacophore Translation
Wilson, Mark E. / University of California Irvine
Comments
Be the first to comment on Mark Wilson's grant